Effect of Traditional Chinese Medicine on In Vitro Fertilization (IVF) Success Rates (TCM-P002)

October 27, 2015 updated by: Pacific Fertility Center

A Randomized, Controlled Clinical Trial of the Effect of Traditional Chinese Medicine on IVF Success Rates

The purpose of this study is to determine the value of combining Traditional Chinese Medicine (TCM) Protocols including acupuncture with In Vitro Fertilization (IVF).

Study Overview

Study Type

Interventional

Enrollment (Actual)

8

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 42 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  1. Subject is able to understand and provide consent
  2. Subject is female, 21-42 years of age at time of screening and has at least one l ovary
  3. Subject BMI is > 18 and < 32
  4. Subject is experiencing primary or secondary infertility
  5. Subject may receive sperm from donated source
  6. Subject's partner has sperm in the ejaculate
  7. Subject's serum basal FSH is < 11 IU/L
  8. Subject's serum basal estradiol level is between 20-80 pg/mL
  9. Subject's TSH level is < 3.0 mv/mL
  10. Subject's prolactin level is < 24 ng/mL
  11. Subject will agree to limit caffeine intake to one cup (76.5 mL/day) by the time of randomization
  12. Subject agrees not to make alterations in diet and lifestyle practices other than those that their Medical Practitioner deems necessary in the best interest of the subject
  13. Subject agrees not to participate in any other research opportunities for the duration of the study

Exclusion Criteria:

  1. Subject is pursuing sex selection
  2. Subject is undergoing treatment with an egg donor
  3. Subject experienced more than 2 previous failed cycles
  4. Subject is undergoing a heparin or lovenox-based protocol
  5. Subject is currently taking herbal therapy (1 week wash-out)
  6. Subject is currently taking co-interventions of moxibustion and cupping
  7. Subject is exhibiting uterine anomalies (i.e.,bicornuate, unicornuate uterus,)
  8. Subject is diagnosed with severe endometriosis defined as endometriomas > 4cm
  9. Subject is currently receiving acupuncture therapy (Subject must agree to a 30 day washout period prior to randomization)
  10. Subject has history of recurrent spontaneous abortions defined as > 3
  11. Subjects with a Beck Depression Inventory (BDI-II) of 29 or higher at screening, indicative of severe depression, will be excluded from the study and referred for further psychological evaluation by our in-house licensed mental health professional.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: IVF-No Acupuncture
IVF with no Traditional Chinese Medicine: Acupuncture
Active Comparator: IVF-Acupuncture
IVF with Traditional Chinese Medicine: Acupuncture
Active arm will receive Acupuncture with their IVF cycle.
Other Names:
  • Acupuncture

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The proportion of subjects who receive an embryo transfer which results in a live birth.
Time Frame: Average of 1 year
Embryo transfer resulting in Live Birth up to 40 weeks gestation
Average of 1 year
The proportion of subjects in the active treatment group experiencing no SAE's attributable to ACU.
Time Frame: Overall to be collected at interim analysis of 138 subjects and at study completion of 276 patients
Overall to be collected at interim analysis of 138 subjects and at study completion of 276 patients

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
1. The proportion of subjects who undergo an embryo transfer which results in implantation as evidenced by USS at 7 weeks.
Time Frame: Average of 4 months
At 7 week ultrasound
Average of 4 months
Effect of the IVF/ICSI treatment on quality of life and psychological factors assessed with the Fertility Quality of Life Questionnaire (FertiQoL 2008) and the Spielberger State Trait Anxiety Inventory (STAI).
Time Frame: Average of two months
Repeat measures at Screening, Treatment Month and at Embryo Transfer
Average of two months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Eldon Schriock, MD, Pacific Fertility Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2011

Primary Completion (Actual)

June 1, 2013

Study Completion (Actual)

June 1, 2013

Study Registration Dates

First Submitted

April 4, 2011

First Submitted That Met QC Criteria

April 6, 2011

First Posted (Estimate)

April 8, 2011

Study Record Updates

Last Update Posted (Estimate)

October 29, 2015

Last Update Submitted That Met QC Criteria

October 27, 2015

Last Verified

October 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2010.097-1 (Esch)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Primary Female Infertility

Clinical Trials on Traditional Chinese Medicine

3
Subscribe